Alumis Inc. (ALMS)
(Delayed Data from NSDQ)
$12.87 USD
+0.16 (1.26%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $12.88 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Price, Consensus and EPS Surprise
ALMS 12.87 +0.16(1.26%)
Will ALMS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ALMS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for ALMS
Alumis reports Q2 results
Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements
Buy Rating Affirmed for Alumis Inc. on Strong Prospects for TYK2 Inhibitor ESK-001
Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis
Alumis initiates patient dosing in ONWARD Phase 3 trial